United States

People: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

21 Oct 2016
Change (% chg)

$-9.01 (-3.01%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Scangos, George 

Dr. George A. Scangos, Ph.D., is the Chief Executive Officer, Director of Biogen Inc., since July 2010. Dr. Scangos has served as our Chief Executive Officer since July 2010. Prior to that, he served as the President and Chief Executive Officer of Exelixis, Inc., a drug discovery and development company, from 1996 to July 2010. From 1993 to 1996, Dr. Scangos served as President of Bayer Biotechnology, where he was responsible for research, business development, process development, manufacturing, engineering and quality assurance of Bayer’s biological products. Before joining Bayer in 1987, Dr. Scangos was a professor of biology at Johns Hopkins University for six years, where he is still an adjunct professor. Dr. Scangos served as non-executive Chairman of Anadys Pharmaceuticals, Inc., a biopharmaceutical company, from 2005 to July 2010 and was a director of the company from 2003 to July 2010. He also served as the Chair of the California Healthcare Institute in 2010 and was a member of the board of the Global Alliance for TB Drug Development until 2010. He completed B.A. in Biology from Cornell University , Ph.D. in Microbiology from University of Massachusetts and Jane Coffin Childs Post-Doctoral Fellow from Yale University,

Basic Compensation

Total Annual Compensation, USD 2,719,710
Restricted Stock Awards, USD 13,015,200
Long-Term Incentive Plans, USD --
All Other, USD 1,139,440
Fiscal Year Total, USD 16,874,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --